Clinical Trial Update: Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU [NA]

View source ↗

Summary

The update summarizes a completed study evaluating whether rapid diagnostic tools BacT/Alert VIRTUO, BioFire BCID2, and REVEAL improve antibiotic optimization f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacteremia

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Bacteremia | NA | Status: COMPLETED